Adding Opdivo to Frontline Chemo Boosts Survival in Advanced GI Cancers
Patients with advanced gastric cancers tended to have better survival outcomes when given Opdivo plus chemotherapy, compared to those who were given chemotherapy alone.
Source: curetoday.com